Seminars in Hematology
Volume 47, Issue 1 , Pages 13-21 , January 2010

Unrelated Umbilical Cord Blood Unit Selection

  • Andromachi Scaradavou

      Affiliations

    • Corresponding Author InformationAddress correspondence to Andromachi Scaradavou, MD, National Cord Blood Program, New York Blood Center, 45-01 Vernon Blvd, New York, NY 11101
  • ,
  • National Cord Blood Program, New York Blood Center

References 

  1. World Marrow Donor Association 2008 annual report. WMDA; 2008;
  2. Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110:4576–4583
  3. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, et al. Outcome of cord blood transplantation from related and unrelated donors (Eurocord Transplant Group and the European Blood and Marrow Transplantation Group). N Engl J Med. 1997;337:373–381
  4. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565–1577
  5. Rocha V, Locatelli F. Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant. 2008;41:207–714
  6. Kamani N, Spellman S, Hurley CK, Barker JN, Smith FO, Oudshoorn M, et al. State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants. Biol Blood Marrow Transplant. 2008;14:1–6
  7. Gluckman E, Rocha V. Cord blood transplantation: state of the art. Hematologica. 2009;94:451–454
  8. Wall DA, Chan KW. Selection of cod blood unit(s) for transplantation. Bone Marrow Transplant. 2008;42:1–7
  9. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611–1618
  10. Rocha V, Wagner JE, Sobocinski KA, Klein JP, Zhang M-J, Horowitz MM, et al. Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med. 2000;342:1846–1854
  11. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, et al. Hematopoietic engraftment and survival in adult recipients of umbilical cord blood from unrelated donors. N Engl J Med. 2001;344:1815–1822
  12. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351:2265–2275
  13. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, et al. Acute Leukemia Working Party of European Blood and Marrow Transplant Group and the Eurocord-Netcord Registry Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276–2285
  14. Eapen M, Rubinstein P, Zhang M-J, Stevens C, Kurtzberg J, Scaradavou A, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: a comparison study. Lancet. 2007;369:1947–1954
  15. Gibbons R. Analysis of the NYBC, NMDP and NHLBI cord blood data, IOM report (Cord blood: establishing a national hematopoietic stem cell bank program). In: Institute of Medicine; 2005;p. 265–273
  16. Scaradavou A, Stevens C, Dobrila L, Zhu T, Jiang S, Daniels D, et al. Cord blood unit mononuclear cell (MNC) dose: effect on transplantation outcome and relevance to processing method and CBU selection [abstract]. ASH Annual Meeting Abstracts. 2008;112:1969
  17. Migliaccio AR, Adamson JW, Stevens CE, Dobrila NL, Carrier CM, Rubinstein P. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood. 2000;96:2717–2722
  18. Prasad VK, Mendizabal A, Parikh SH, Szabolcs P, Driscoll TA, Page K, et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood. 2008;112:2979–2989
  19. Page KM, Mendizabal A, Waters-Pick B, Avrutsky S, Reese M, Prasad V, et al. Post thaw colony forming units (CFU) is a strong independent predictor of engraftment after unrelated umbilical cord blood transplantation (UCBT) [abstract]. ASH Annual Meeting Abstracts. 2007;110:3282
  20. Wagner E, Duval M, Dalle J-H, Morin H, Bizier S, Champagne J, et al. Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks. Transfusion. 2006;46:1190–1198
  21. Kurtzberg J, Balber A, Mendizabal A, Reese M, Kaestner A, Gentry T, et al. Preliminary results of a pilot trial of unrelated umbilical cord blood transplantation (UCBT) augmented with cytokine-primed aldehyde dehydrogenase-bright (ALDHbr) cells [abstract]. ASH Annual Meeting Abstracts. 2006;108:3641
  22. Barker JN, Scaradavou A, Stevens C, Rubinstein P. The dose-match interaction in umbilical cord blood (UCB) transplantation: an analysis of the impact of cell dose and HLA-match on the disease-free survival (DFS) of 989 patients transplanted with single units for hematologic malignancy [abstract]. ASH Annual Meeting Abstracts. 2007;110:105
  23. Barker JN, Scaradavou A, Stevens C, Rubinstein P. The dose-match interaction in umbilical cord blood (UCB) transplantation: an analysis of the impact of cell dose and HLA-match on the disease-free survival (DFS) of 989 patients transplanted with single units for hematologic malignancy [abstract]. Los Angeles: Sixth Annual International UCB Symposium; June 2008;
  24. Rubinstein P, Stevens CE, Scaradavou A, Carrier C, Carpenter C. HLA in cord blood transplantation: role of homozygosity in engraftment, GvHD, relapse and survival [abstract]. ASH Annual Meeting Abstracts. 2003;102:478
  25. Ottinger HD, Ferencik S, Beelen DW, Lindemann M, Peceny R, Elmaagacli AH, et al. Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA matched unrelated donors. Blood. 2003;102:1131–1137
  26. Matsuno N, Wake A, Uchida N, Ishiwata K, Aroaka H, Takagi S, et al. Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation. Blood. 2009;114:1689–1695
  27. Stevens CE, Rubinstein P, Scaradavou A. HLA matching in cord blood transplantation: clinical outcome and implications for cord blood unit selection and inventory size and ethnic composition [abstract]. ASH Annual Meeting Abstracts. 2006;108:3104
  28. van Rood JJ, Roelen DL, Claas FH. The effect of noninherited maternal antigens in allogeneic transplantation. Semin Hematol. 2005;42:104–111
  29. van Rood JJ, Oudshoorn M. When selecting a HLA mismatched stem cell donor consider donor immune status. Curr Opinion Immunol. 2009;21:1–6
  30. van Rood JJ, Stevens CE, Schmits J, Carrier C, Carpenter C, Scaradavou A. Re-exposure of cord blood to non-inherited maternal HLA antigens improves transplant outcome in hematological malignancies and might enhance its anti-leukemic effect. Proc Natl Acad Sci U S A. Epub ahead of print doi 10.1073/pnas.0910310106.
  31. Kogler G, Enszmann J, Rocha V, Gluckman E, Wernet P. High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome. Bone Marrow Transplant. 2005;36:1033–1041
  32. Kurtzberg J, Prasad VK, Carter SL, Wagner JE, Baxter-Lowe LA, Wall D, et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood. 2008;112:4318–4327
  33. Eapen M, Klein J, Sanz G, Anasetti C, Garcia J, Gluckman E, et al. Donor-recipient matching at the HLA-C locus and early outcomes after unrelated umbilical cord blood transplant (UCBT) [abstract]. ASH Annual Meeting Abstracts. 2008;112:153
  34. Willemze R, Rodrigues CA, Labopin M, Sanz G, Michel G, Socie G, et al. KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia. 2009;23:492–500
  35. Brunstein CG, Wagner JE, Weisdorf DJ, Cooley S, Noreen H, Barker JN, et al. Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity. Blood. 2009;113:5628–5634
  36. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGrave PB, et al. Transplantation of two partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood. 2005;105:1343–1347
  37. Brunstein CG, Barker JN, Weisdorf DJ, DeFor TE, Miller JS, Blazar BR, et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood. 2007;110:3064–3070
  38. Barker JN, Abboud M, Rice RD, Hawke R, Schaible A, Heller G, et al. A “no-wash” albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infection reactions. Biol Blood Marrow Transplant. 2009;Epub ahead of print. DOI 10.1016/jbbmt.2009.08.009
  39. Rocha V, Gluckman E. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors. Br J Haematol. 2009;147:262–274
  40. Grewal SS, Barker JN, Davies SM, Wagner JE. Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?. Blood. 2003;101:4233–4244
  41. Gluckman E, Rocha V, Arcese W, Michel G, Sanz G, Chan KW, et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol. 2004;32:397–407
  42. Rio B, Furst S, Renaud M, Legrand F, Tabrizi R, Uzunov M, et al. Encouraging results of unrelated cord blood transplantation (UCBT) after homogenous reduced intensity conditioning (RIC) in adults with hematological malignancies: impact of HLA disparities on outcomes. A French multicentre study on behalf of the SFGM-TC and Eurocord [abstract]. Bone Marrow Transplant. 2009;43(Suppl 1):107
  43. Guidance for industry (potency tests for cellular and gene therapy products). (Draft Guidance) Washington, DC: US Food and Drug Administration; October 2008;
  44. Rodriguez L, Garcia J, Querol S. Predictive utility of the attached segment in the quality control of a cord blood graft. Biol Blood Marrow Transplant. 2005;11:247–251
  45. Albano MS, Stevens CE, Dobrila L, Scaradavou A, Rubinstein P. Colony-forming-unit (CFU) assay with high-resolution digital imaging: a reliable system for cord blood (CB) CFU evaluation [abstract]. Tampa, FL: ASBMT Annual Meeting Abstracts; February 2009;
  46. McCullough J, McKenna D, Kadidlo D, Maurer D, Noreen HJ, French K, et al. Mislabeled units of umbilical cord blood detected by a quality assurance program at the transplantation center. Blood. 2009;114:1684–1688
  47. Broxmeyer HE, Srour EF, Hangoc G, Cooper S, Anderson SA, Bodine DM. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc Natl Acad Sci U S A. 2003;100:645–650
  48. Scaradavou A, Stevens CE, Dobrila L, Sung D, Rubinstein P. “Age” of the cord blood (CB) unit: impact of long-term cryopreservation and storage on transplant outcome [abstract]. ASH Annual Meeting Abstracts. 2007;110:2033
  49. Chow R, Nademanee A, Rosenthal J, Karanes C, Jaing T-H, Graham M, et al. Analysis of hematopoietic cell transplants using plasma-depleted cord blood products that are not red cell reduced. Biol Blood Marrow Transplant. 2007;13:1346–1357

PII: S0037-1963(09)00134-6

doi: 10.1053/j.seminhematol.2009.10.003

Seminars in Hematology
Volume 47, Issue 1 , Pages 13-21 , January 2010